Glycemic variability: too often overlooked in type 2 diabetes?
Look beyond the HbA1c average, and consider introducing insulin earlier in the disease process.
Johnson
Eric L
EL
Department of Family and Community Medicine, University of North Dakota School of Medicine and Health Sciences; Altru Diabetes Center, Grand Forks, ND, USA. ejohnson@medicine.nodak.edu
D001786:Blood Glucose / Q000032:analysis*; D002940:Circadian Rhythm; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy; D019317:Evidence-Based Medicine; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D018384:Oxidative Stress
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin